This announcement is a separate document:
康辰药业关于公司2023年限制性股票激励计划首次授予部分第一个解除限售期解除限售条件成就的公告
Beijing Konruns Pharmaceutical's announcement about the first release of the restricted stock incentive plan in 2023 and the achievement of the first unlocking condition
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.